Kramer Levin Expands IP Group with the Hiring of Pharma and Biotech Patent Litigator Christine Willgoos
For Seventh Consecutive Year, Kramer Levin is Major Sponsor of Archtober 2014
Please use the form below to search for any relevant publications pertaining to your specific needs. If you would like to be added to Kramer Levin's publications distribution list, please click onto the Publications Sign Up in the right side bar.
Corporate partner Christopher S. Auguste was quoted in a PIPEs Report article about the "Private Investment in Public Equity" report that Kramer Levin underwrote and co-published with Rodman & Renshaw. The survey found that most expect deal flow to increase in the next 12 to 18 months. Auguste was quoted as saying that more deal are being discussed as regulatory changes will help drive PIPE investing. SEC rules for registered directs and S-3 offerings were changes in 2008 as a way to make offerings easier on the issuer and more liquid for investors. Those changes, said Auguste, were going to be positive, but the decline in the market halted any upswing in the PIPEs market.